1. Home
  2. NTCT vs OCUL Comparison

NTCT vs OCUL Comparison

Compare NTCT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$42.92

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.88

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
OCUL
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
NTCT
OCUL
Price
$42.92
$8.88
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$31.00
$23.56
AVG Volume (30 Days)
528.6K
2.7M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
125.39
N/A
EPS
1.30
N/A
Revenue
$891,820,000.00
$1,990,000.00
Revenue This Year
$6.02
$7.93
Revenue Next Year
$2.55
$96.07
P/E Ratio
$31.90
N/A
Revenue Growth
N/A
3.48
52 Week Low
$20.40
$6.23
52 Week High
$42.37
$16.44

Technical Indicators

Market Signals
Indicator
NTCT
OCUL
Relative Strength Index (RSI) 72.45 49.39
Support Level $26.16 $8.36
Resistance Level N/A $9.93
Average True Range (ATR) 1.32 0.42
MACD 0.15 0.02
Stochastic Oscillator 99.32 57.35

Price Performance

Historical Comparison
NTCT
OCUL

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: